BIONOMICS LIMITED - AM
0,4050
08-ноября-24 12:07:08
15 мин. задержка
Акции
+0,0250
+6,58%
Сегодняшний диапазон
0,3402 - 0,4700
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
23 авг 2023 05:00:00 Источник Nasdaq GlobeNewswire
-
Quarterly Activities and Cashflow Report
31 июл 2023 05:00:00 Источник Nasdaq GlobeNewswire
-
03 июл 2023 05:00:00 Источник Nasdaq GlobeNewswire
-
Bionomics to Present at Upcoming June Investor Conferences
15 июн 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
30 май 2023 05:00:00 Источник Nasdaq GlobeNewswire
-
Quarterly Activities and Cashflow Report
28 апр 2023 05:00:00 Источник Nasdaq GlobeNewswire
-
27 апр 2023 05:00:00 Источник Nasdaq GlobeNewswire
-
08 мар 2023 18:00:30 Источник Nasdaq GlobeNewswire
-
23 фев 2023 05:00:00 Источник Nasdaq GlobeNewswire
-
Quarterly Activities and Cashflow Report
30 янв 2023 17:23:46 Источник Nasdaq GlobeNewswire
-
Bionomics Reports Topline Results in PREVAIL Phase 2 Study of BNC210 in Social Anxiety Disorder
18 дек 2022 18:34:26 Источник Nasdaq GlobeNewswire
-
Bionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive Officer
15 дек 2022 17:35:25 Источник Nasdaq GlobeNewswire
-
02 дек 2022 05:00:00 Источник Nasdaq GlobeNewswire
-
21 ноя 2022 17:13:51 Источник Nasdaq GlobeNewswire
-
16 ноя 2022 17:36:15 Источник Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in Upcoming November Investor Conferences
02 ноя 2022 05:00:00 Источник Nasdaq GlobeNewswire
-
Quarterly Activities Report for September 2022
25 окт 2022 05:00:00 Источник Nasdaq GlobeNewswire
-
Bionomics Receives R&D Tax Incentive Refund for FY2022 of A$4.6 million
18 окт 2022 05:00:00 Источник Nasdaq GlobeNewswire
-
Bionomics Limited to Participate in the Cantor Neurology & Psychiatry Conference
04 окт 2022 05:00:00 Источник Nasdaq GlobeNewswire
-
Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder
21 сен 2022 05:00:00 Источник Nasdaq GlobeNewswire